Revolution Medicines

ISIN US76155X1000

WKN A2PYWG

Market cap (in EUR)

37,504 m

Country

United States

Sector

Healthcare

Dividend yield

0.00%

Overview

Description

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Show more Show less

Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR	37,504 m
EPS, EUR	-7.56
P/B ratio	16.6
P/E ratio	-
Dividend yield	0.00%

Income statement (2025)

Revenue, EUR	-
Net income, EUR	-1,003 m
Profit margin	-

What ETF is Revolution Medicines in?

There are 29 ETFs which contain Revolution Medicines. All of these ETFs are listed in the table below. The ETF with the largest weighting of Revolution Medicines is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).

ETF	Weight	Investment focus	Fund size (in m EUR)
UBS Core MSCI World UCITS ETF USD acc	0.04%	Equity World	10,500
iShares MSCI World UCITS ETF (Dist)	0.03%	Equity World	8,317
Amundi MSCI World Swap II UCITS ETF Dist	0.03%	Equity World	8,854
iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist)	0.09%	Equity World Health Care Social/Environmental	588
Xtrackers MSCI World UCITS ETF 1D	0.04%	Equity World	4,883
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist)	0.47%	Equity United States Small Cap	235
JPMorgan US Growth Equity Active UCITS ETF EUR Hedged (acc)	0.14%	Equity United States Growth	7
iShares MSCI USA CTB Enhanced ESG UCITS ETF USD (Dist)	0.10%	Equity United States Social/Environmental	16,154
iShares MSCI North America UCITS ETF	0.04%	Equity North America	1,340
UBS Core MSCI World UCITS ETF USD dis	0.04%	Equity World	2,001
iShares MSCI World Screened UCITS ETF USD (Dist)	0.03%	Equity World Social/Environmental	1,099
iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist)	0.01%	Equity World Social/Environmental Climate Change	189
JPMorgan Global Research Enhanced Index Equity Active UCITS ETF USD (dist)	0.04%	Equity World Social/Environmental	1,767
UBS Core MSCI World UCITS ETF hGBP dis	0.04%	Equity World	114
JPMorgan All Country Research Enhanced Index Equity Active UCITS ETF USD (dist)	0.03%	Equity World Social/Environmental	61
UBS Core MSCI USA UCITS ETF USD dis	0.05%	Equity United States	1,326
JPMorgan US Growth Equity Active UCITS ETF USD (acc)	0.14%	Equity United States Growth	480
Amundi MSCI North America ESG Broad Transition UCITS ETF Dist	0.04%	Equity North America Social/Environmental Climate Change	41
iShares MSCI ACWI UCITS ETF USD (Acc)	0.03%	Equity World	31,066
iShares MSCI USA Screened UCITS ETF USD (Dist)	0.05%	Equity United States Social/Environmental	1,481
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.04%	Equity World Social/Environmental	606
UBS Core MSCI World UCITS ETF hEUR acc	0.04%	Equity World	962
UBS Core MSCI USA UCITS ETF EUR Hedged dis	0.05%	Equity United States	195
iShares MSCI World CTB Enhanced ESG UCITS ETF USD (Dist)	0.02%	Equity World Social/Environmental	667
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	2.78%	Equity United States Health Care Biotech	68
JPMorgan US Growth Equity Active UCITS ETF USD (dist)	0.14%	Equity United States Growth	1
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing	0.06%	Equity North America Social/Environmental	28
Vanguard Russell U.S. Mid-Cap UCITS ETF USD Dist	0.26%	Equity United States Mid Cap	3
iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist)	0.20%	Equity United States Momentum	21

Change your settings